Thiocarbamate inhibitors of alpha-4 integrins

Details for Australian Patent Application No. 2004240940 (hide)

Owner Genentech, Inc.

Inventors Jackson, David Y.

Agent Griffith Hack

Pub. Number AU-A-2004240940

PCT Pub. Number WO2004/103967

Priority 60/472,072 20.05.03 US

Filing date 19 May 2004

Wipo publication date 2 December 2004

International Classifications

C07D 295/20 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 491/08 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 217/14 Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

A61K 031/5375 - 1,4-Oxazines, e.g. morpholine

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/103967 Priority application(s): WO2004/103967

15 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004240944-Method and system for microfluidic device and imaging thereof

2004240938-Mannose-6-phosphonate compounds for the treatment of inflammatory diseases